Qube Research & Technologies Ltd
Position in TBPH — Theravance Biopharma, Inc.
CIK 1729829
LONDON, X0
Position in TBPH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,698,146
-$4,161,001 QoQ
Shares Held
289,473
-38.9% QoQ
Ownership
0.562%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $1,746,661,431 across 187 Biotechnology names. TBPH ranks #68 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 7 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
262,553 | $49,635,644 |
All Filings in TBPH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,698,146 | 289,473 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,859,147 | 473,498 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,081,300 | 211,048 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,264,238 | 205,280 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,017,475 | 113,939 | Shares | Sole | 2025-05-15 | |
| 2020-09-30 | $252,734 | 17,094 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $275,451 | 13,123 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||